These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 35844258)

  • 1. Current status and future directions for a neurotoxicity hazard assessment framework that integrates
    Crofton KM; Bassan A; Behl M; Chushak YG; Fritsche E; Gearhart JM; Marty MS; Mumtaz M; Pavan M; Ruiz P; Sachana M; Selvam R; Shafer TJ; Stavitskaya L; Szabo DT; Szabo ST; Tice RR; Wilson D; Woolley D; Myatt GJ
    Comput Toxicol; 2022 May; 22():. PubMed ID: 35844258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of neurotoxicology (NT)/developmental neurotoxicology (DNT) adverse outcome pathways and key event linkages with in vitro DNT screening assays.
    Pitzer EM; Shafer TJ; Herr DW
    Neurotoxicology; 2023 Dec; 99():184-194. PubMed ID: 37866692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico toxicology protocols.
    Myatt GJ; Ahlberg E; Akahori Y; Allen D; Amberg A; Anger LT; Aptula A; Auerbach S; Beilke L; Bellion P; Benigni R; Bercu J; Booth ED; Bower D; Brigo A; Burden N; Cammerer Z; Cronin MTD; Cross KP; Custer L; Dettwiler M; Dobo K; Ford KA; Fortin MC; Gad-McDonald SE; Gellatly N; Gervais V; Glover KP; Glowienke S; Van Gompel J; Gutsell S; Hardy B; Harvey JS; Hillegass J; Honma M; Hsieh JH; Hsu CW; Hughes K; Johnson C; Jolly R; Jones D; Kemper R; Kenyon MO; Kim MT; Kruhlak NL; Kulkarni SA; Kümmerer K; Leavitt P; Majer B; Masten S; Miller S; Moser J; Mumtaz M; Muster W; Neilson L; Oprea TI; Patlewicz G; Paulino A; Lo Piparo E; Powley M; Quigley DP; Reddy MV; Richarz AN; Ruiz P; Schilter B; Serafimova R; Simpson W; Stavitskaya L; Stidl R; Suarez-Rodriguez D; Szabo DT; Teasdale A; Trejo-Martin A; Valentin JP; Vuorinen A; Wall BA; Watts P; White AT; Wichard J; Witt KL; Woolley A; Woolley D; Zwickl C; Hasselgren C
    Regul Toxicol Pharmacol; 2018 Jul; 96():1-17. PubMed ID: 29678766
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bassan A; Alves VM; Amberg A; Anger LT; Auerbach S; Beilke L; Bender A; Cronin MTD; Cross KP; Hsieh JH; Greene N; Kemper R; Kim MT; Mumtaz M; Noeske T; Pavan M; Pletz J; Russo DP; Sabnis Y; Schaefer M; Szabo DT; Valentin JP; Wichard J; Williams D; Woolley D; Zwickl C; Myatt GJ
    Comput Toxicol; 2021 Nov; 20():. PubMed ID: 35340402
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Bassan A; Alves VM; Amberg A; Anger LT; Beilke L; Bender A; Bernal A; Cronin MTD; Hsieh JH; Johnson C; Kemper R; Mumtaz M; Neilson L; Pavan M; Pointon A; Pletz J; Ruiz P; Russo DP; Sabnis Y; Sandhu R; Schaefer M; Stavitskaya L; Szabo DT; Valentin JP; Woolley D; Zwickl C; Myatt GJ
    Comput Toxicol; 2021 Nov; 20():. PubMed ID: 35721273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network.
    Spînu N; Cronin MTD; Lao J; Bal-Price A; Campia I; Enoch SJ; Madden JC; Mora Lagares L; Novič M; Pamies D; Scholz S; Villeneuve DL; Worth AP
    Comput Toxicol; 2022 Feb; 21():100206. PubMed ID: 35211661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J; Settivari R; LeBaron MJ; Marty MS
    Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing.
    Serafini MM; Sepehri S; Midali M; Stinckens M; Biesiekierska M; Wolniakowska A; Gatzios A; Rundén-Pran E; Reszka E; Marinovich M; Vanhaecke T; Roszak J; Viviani B; SenGupta T
    Arch Toxicol; 2024 May; 98(5):1271-1295. PubMed ID: 38480536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations.
    Sachana M; Shafer TJ; Terron A
    Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33498772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental Neurotoxicity of Environmentally Relevant Pharmaceuticals and Mixtures Thereof in a Zebrafish Embryo Behavioural Test.
    Atzei A; Jense I; Zwart EP; Legradi J; Venhuis BJ; van der Ven LTM; Heusinkveld HJ; Hessel EVS
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids and developmental neurotoxicity: Utilizing toxicogenomics to enhance adverse outcome pathways and testing strategies.
    Chen H; Chidboy MA; Robinson JF
    Reprod Toxicol; 2020 Sep; 96():102-113. PubMed ID: 32544423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Approaches in Predictive Genetic Toxicology.
    Sinha M; Dhawan A; Parthasarathi R
    Methods Mol Biol; 2019; 2031():351-373. PubMed ID: 31473971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M; Willett C; Pistollato F; Bal-Price A
    Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem Cells in Neurotoxicology/Developmental Neurotoxicology: Current Scenario and Future Prospects.
    Singh S; Srivastava A; Kumar V; Pandey A; Kumar D; Rajpurohit CS; Khanna VK; Yadav S; Pant AB
    Mol Neurobiol; 2016 Dec; 53(10):6938-6949. PubMed ID: 26666665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
    Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
    Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental toxicology evaluations--issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies.
    Ladics GS; Chapin RE; Hastings KL; Holsapple MP; Makris SL; Sheets LP; Woolhiser MR; Burns-Naas LA
    Toxicol Sci; 2005 Nov; 88(1):24-9. PubMed ID: 16120748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.
    Coecke S; Goldberg AM; Allen S; Buzanska L; Calamandrei G; Crofton K; Hareng L; Hartung T; Knaut H; Honegger P; Jacobs M; Lein P; Li A; Mundy W; Owen D; Schneider S; Silbergeld E; Reum T; Trnovec T; Monnet-Tschudi F; Bal-Price A
    Environ Health Perspect; 2007 Jun; 115(6):924-31. PubMed ID: 17589601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of
    Myatt GJ; Bassan A; Bower D; Johnson C; Miller S; Pavan M; Cross KP
    Comput Toxicol; 2022 Feb; 21():. PubMed ID: 35036665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental neurotoxicity testing: a path forward.
    Crofton KM; Mundy WR; Shafer TJ
    Congenit Anom (Kyoto); 2012 Sep; 52(3):140-6. PubMed ID: 22925214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicology risk assessment guidelines: developmental neurotoxicology.
    Tilson HA
    Neurotoxicology; 2000; 21(1-2):189-94. PubMed ID: 10794399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.